Revvity Poland

PerkinElmer is a company that provides a range of products and services to support scientific discovery, measurement, and testing across various industries, including biopharma, applied solutions, and food solutions. The company offers a portfolio of instruments, reagents, and software to help laboratories, manufacturing facilities, and other organizations optimize their workflows, ensure compliance, and improve productivity. Specifically, PerkinElmer provides solutions for testing and analysis in areas such as environmental science, agriculture, food safety, and pharmaceuticals, using technologies like spectrometry, chromatography, and molecular diagnostics. The company also offers services like asset management, compliance and validation, and scientific consulting to support its customers' needs. Overall, PerkinElmer's core business is focused on enabling scientific progress and innovation through its products and services.

Revvity Poland provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. With a focus on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection, and diagnosis, informatics, and more, the company revolutionizes healthcare. Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia, and governments, with over $3 billion in revenue and 11,000 employees, and is part of the S&P 500 index with customers in over 190 countries. The company's product and service offerings include research and development solutions, clinical and diagnostics, platforms and automation, and advanced services and licensing.

At Revvity, “impossible” is inspiration, and ""can't be done"" is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. With more than $3 billion in revenue and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries.

RESEARCH & DEVELOPMENT
Genomic Analysis
Protein Analysis
Cell Analysis
Research Solutions

SIGNALS SOFTWARE

CLINICAL & DIAGNOSTICS
Reproductive Health
Infectious Diseases
Autoimmunity
Endocrinology
Allergy
Cancer
Neurodegeneration
Rapid Patient Testing

PLATFORMS & AUTOMATION
Sample Prep
Automated Liquid Handlers
Integrated Laboratory Automation
Detection
Imaging
In Vitro Diagnostics (IVD) Platforms & Automation

ADVANCED SERVICES & LICENSING
Pharma Services
Licensing
Clinical Services
OEM Solutions